There is some speculation that bone marrow-derived cells (BMDCs), along with stromal cells, play an important role in the development of resistance to those anti-VEGF therapies, highlighting the importance of studying the tumor microenvironment when new therapies are considered. Here, VEGFA is linked to neoplasm.